The General Court has given eight judgments on a Commission fining decision concerning patent settlements entered into by Servier and five competitor producers of generic drugs, reducing the fines from a total of € 428 million to € 315 million. The Court broadly upheld the fines based on Article 101 of the EU Treaty, which prohibits anti-competitive agreements, albeit annulling one and reducing another. But it annulled the fine on Servier to the extent that it was based on the Article 102 prohibition of abuse of a dominant market position, reducing Servier’s total fine from € 331 million to € 228 million. Further EU legal developments in this area are in the immediate pipeline. Most significantly pay-for-delay issues are currently before the European Court of Justice (ECJ) in the context
The EU General Court rules that pay-for-delay patent settlements can be illegal agreements but annuls abuse of dominance finding (Servier)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.